Wed, Apr 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers July 2012

Q&A: Rachel Minard: How to avoid the kiss of death when trying to raise assets

Rachel Minard: how to avoid the kiss of death when trying to raise assets

Rachel Minard

Rachel Minard built four funds of hedge funds firms and sits on the Investment Sub-Committee for the Westover School Endowment, which allocates to hedge funds. After 20 years raising more than $10bn across 20 countries, she started, in San Francisco, Minard Capital in 2011, the first outsourced hedge fund marketing firm that is not a broker/dealer or third-party marketer. She is the author of two new books coming out next year, The Art of the Institutional Sale, and Speaking in Thumbs: The Handbook of Empathy. She also sits on several industry boards and one of the founders and Executive Committee of the Association of Women in Alternative Investing.

She shares with Opalesque her recommendations to emerging managers, warns about complacency and lack of preparation and explains the institutional investor's perspective. She also talks about her two upcoming books: one about the sell cycle, and the other about empathy, a "personal currency."

Â

Opalesque: What are your recommendations to emerging managers in terms of marketing strategy?

Rachel Minard: Start-up hedge funds need to approach their growth in a pragmatic way.

The first step is to do with a sober holistic assessment, which is to say ‘do I have a strategy that in and of itself is unique enough to secure market share?' The next one would be ‘who is the natural buyer for this type ......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Opalesque Exclusive: WBB enters buy-side with new healthcare long/short strategy[more]

    Benedicte Gravrand, Opalesque Geneva: WBB Securities, a US financial services firm and boutique investment bank since 2001, has a long history within the biotech industry. Managing partner Steve Brozak has been associated with biotech for the last 25-30 years, and was involved with some of the mo